A phase II study of combination therapy with 5′-deoxy-5-fluorouridine and cisplatin in the treatment of advanced gastric cancer with primary foci - Concepedia

Concepedia

Publication | Closed Access

A phase II study of combination therapy with 5′-deoxy-5-fluorouridine and cisplatin in the treatment of advanced gastric cancer with primary foci

45

Citations

23

References

1993

Year

Wasaburo Koizumi, Minoru Kurihara, T Sasai, Shigeaki Yoshida, Kimitomo Morise, Akimichi Imamura, S Akazawa, Takashi Betsuyaku, Shunji Ohkubo, Hiroshi Takahashi,

Abstract

Combined therapy with 5'-DFUR and CDDP is a safe and effective treatment regimen for advanced gastric cancers with primary foci which stresses the patient's quality of life, especially when used in an outpatient setting.

References

	Year	Citations
cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice. Schabel Fm, Trader Mw, Laster Wr, PubMed PathologyMetronomic ChemotherapyAdvanced P388Cancer ChemotherapyTumor Biology	1980	433
Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells. Kevin J. Scanlon, Edward M. Newman, Yuzhi Lu, Proceedings of the National Academy of Sciences Tight BindingBiochemical BasisCancer BiologyTumor BiologyOvarian Cancer	1986	369
Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer. P. Preusser, H. Wilke, W. Achterrath, Journal of Clinical Oncology Median Survival TimeGastrointestinal OncologyMedicineSurgical PathologyPharmacology	1989	302
Role of uridine phosphorylase for antitumor activity of 5'-deoxy-5-fluorouridine. Hideo Ishitsuka, Masanori Miwa, Kenji Takemoto, PubMed Molecular PharmacologyMedicinal ChemistryOther Fluorinated PyrimidinesOncologyMedicine	1980	139
Fluorinated pyrimidine nucleosides. 3. Synthesis and antitumor activity of a series of 5'-deoxy-5-fluoropyrimidine nucleosides Alan F. Cook, Michael J. Holman, M. J. KRAMER, Journal of Medicinal Chemistry Pharmaceutical ScienceBioorganic ChemistryAntitumor Activity5'-Deoxy-5-fluoropyrimidine NucleosidesAltmetric Attention Score	1979	137
A phase II study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomas. C G Moertel, J. Peter Rubin, M J O'Connell, Journal of Clinical Oncology Surgical OncologyGastroenterologyPathologyPhase Ii StudySurgery	1986	133
Activation of 5'-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors. Akira Kono, Yasuhiro Hara, SETSURO SUGATA, Chemical and Pharmaceutical Bulletin Chemoprevention StrategyKm ValuesThymidine Phosphorylase PreparationTumor BiologyPyrimidine Nucleoside Phosphorylases	1983	131
Tumor inhibitory effects of a new fluorouracil derivative: 5′-deoxy-5-fluorouridine Wendy B. Bollag, H.R. Hartmann European Journal of Cancer (1965) Medicinal ChemistryOncologyNew FluorouracilMedicinePharmacotherapy	1980	129
5-fluorouracil, adriamycin, and mitomycin-c (fam) combination chemotherapy in the treatment of advanced gastric cancer John S. Macdonald, Paul V. Woolley, Tariyln Smythe, Cancer Surgical OncologyOncologyCombination ChemotherapyGastrointestinal OncologyAdvanced Gastric Cancer	1979	119
Randomized study of combination chemotherapy in unresectable gastric cancer Michael J. O’Connell Cancer Surgical OncologyCombination ChemotherapyMarch 1981Health SciencesProportional Hazards Model	1984	66

Page 1